Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities

被引:31
作者
Hume, Heather [1 ]
Chasen, Stephen T. [1 ]
机构
[1] Cornell Univ, Dept Obstet & Gynecol, Weill Med Coll, New York, NY 10021 USA
关键词
abortion; Down syndrome; noninvasive prenatal testing (NIPT); prenatal diagnosis; UNITED-STATES POPULATION; GESTATIONAL-AGE; ANEUPLOIDY; RISK; SERVICES;
D O I
10.1016/j.ajog.2015.06.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our objective was to evaluate changes in the timing of prenatal diagnosis and abortion for chromosomal abnormalities over the past 10 years. STUDY DESIGN: This retrospective review identified singleton pregnancies with fetal chromosomal abnormalities that were diagnosed from 2005-2014 and included Down syndrome, Trisomy 18, and Trisomy 13. The study period was divided into 3 intervals: 2005-2006; 2007-2011; and 2012-2014. Gestational ages at prenatal diagnosis and abortion were compared over these intervals. RESULTS: The 213 cases included 142 cases of Down syndrome (66.7%), 47 cases of Trisomy 18 (22.1%), and 24 cases of Trisomy 13 (11.3%). Two hundred one women (94.4%) chose to undergo abortion. The median gestational ages at prenatal diagnosis and abortion for Trisomy 18 or 13 were 12 weeks (interquartile range, 12-13 weeks) and 13 weeks (interquartile range, 12-15.5 weeks) and did not change over the study period. In contrast, in pregnancies with Down syndrome, the median gestational age at prenatal diagnosis (16, 13, and 12 weeks; P<. 001) and abortion (17, 14, and 13 weeks; P <.001) both decreased significantly over the study intervals. In Down syndrome pregnancies, the proportion of women who underwent chorionic villus sampling significantly increased over the 3 study intervals (36%, 63%, and 86%; P <.001). CONCLUSION: Since 2005, the gestational ages at prenatal diagnosis and abortion for Down syndrome have declined significantly. These changes are likely attributable to improvements in early screening that leads to higher rates of chorionic villus sampling.
引用
收藏
页码:545.e1 / 545.e4
页数:4
相关论文
共 12 条
  • [1] ACOG Committee on Practice Bulletins, 2007, ACOG COMM PRACT B SC
  • [2] [Anonymous], NON PREN TEST FET AN
  • [3] Risk factors for legal induced abortion-related mortality in the United States
    Bartlett, LA
    Berg, CJ
    Shulman, HB
    Zane, SB
    Green, CA
    Whitehead, S
    Atrash, HK
    [J]. OBSTETRICS AND GYNECOLOGY, 2004, 103 (04) : 729 - 737
  • [4] First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population
    Chasen, ST
    Sharma, G
    Kalish, RB
    Chervenak, FA
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 22 (02) : 149 - 151
  • [5] Gestational age at abortion: The impact of first-trimester risk assessment for aneuploidy
    Chasen, Stephen T.
    Kalish, Robin B.
    Chervenak, Frank A.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (03) : 839 - 842
  • [6] Change in abortion services after implementation of a restrictive law in Texas
    Grossman, Daniel
    Baum, Sarah
    Fuentes, Liza
    White, Kari
    Hopkins, Kristine
    Stevenson, Amanda
    Potter, Joseph E.
    [J]. CONTRACEPTION, 2014, 90 (05) : 496 - 501
  • [7] Abortion in the United States: Incidence and access to services, 2005
    Jones, Rachel K.
    Zolna, Mia R. S.
    Stanley, K.
    Henshaw
    Finer, Lawrence B.
    [J]. PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2008, 40 (01) : 6 - 16
  • [8] Malone FD, 2005, OBSTET GYNECOL, V106, P288
  • [9] Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011)
    Natoli, Jaime L.
    Ackerman, Deborah L.
    McDermott, Suzanne
    Edwards, Janice G.
    [J]. PRENATAL DIAGNOSIS, 2012, 32 (02) : 142 - 153
  • [10] Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials
    Perni, SC
    Predanic, M
    Kalish, RB
    Chervenak, FA
    Chasen, ST
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 194 (01) : 127 - 130